Halozyme Expects Hylenex Exclusivity Issues To Be Resolved Soon
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approved Hylenex on Dec. 2 as the first recombinant human hyaluronidase product.
You may also be interested in...
Roche Invests In Halozyme Biologics Delivery Platform
Halozyme’s Enhanze technology could be used with virtually all biologics to improve drug delivery, the company says.
Roche Invests In Halozyme Biologics Delivery Platform
Halozyme’s Enhanze technology could be used with virtually all biologics to improve drug delivery, the company says.
FDA “Unable” To Act On Hylenex By User Fee Deadline
Approval of Halozyme Therapeutics’ hyaluronidase product could be bogged down by ongoing legal arguments over Ista’s Vitrase exclusivity.